Search

Search results

108 results found

Contact

Applicants may contact the HMS Senior Director, Translational Research, Dr. Ifat Rubin-Bejerano ( ifat_rubin-bejerano@hms.harvard.edu), with questions about the submission, review and selection process for pre-proposals, or any general questions about the program.

Five-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial

Hutton, David, Joshua Stein, Adam Glassman, Neil Bressler, Lee Jampol, Jennifer Sun, and DRCR Retina Network. 2019. “Five-Year Cost-Effectiveness of Intravitreous Ranibizumab Therapy Vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial”. JAMA Ophthalmol, 1-9.